L2 Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,014
Closed -$692K 167
2023
Q1
$692K Buy
2,014
+86
+4% +$29K 0.38% 69
2022
Q4
$705K Buy
1,928
+341
+21% +$121K 0.44% 68
2022
Q3
$513K Buy
1,587
+196
+14% +$62.1K 0.35% 76
2022
Q2
$451K Buy
1,391
+25
+2% +$7.5K 0.33% 81
2022
Q1
$391K Buy
1,366
+220
+19% +$56.6K 0.22% 97
2021
Q4
$317K Buy
+1,146
New +$291K 0.22% 93
2020
Q2
Sell
-5,659
Closed -$785K 70
2020
Q1
$785K Buy
5,659
+308
+6% +$42.3K 0.88% 42
2019
Q4
$703K Buy
+5,351
New +$620K 0.62% 52

Other funds holding LLY

L2 Asset Management's LLY Position: Q2 2023 in Review

L2 Asset Management sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 2,014 shares — an estimated $692K sold.

L2 Asset Management first reported a position in LLY in Q4 2019 and held it in 8 quarters. The position peaked at $785K in Q1 2020. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • L2 Asset Management reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • L2 Asset Management sold 2,014 Eli Lilly shares in Q2 2023, an estimated $692K.
  • L2 Asset Management first reported a position in Eli Lilly in Q4 2019 and held it in 8 quarters.
  • L2 Asset Management's Eli Lilly position peaked at $785K in Q1 2020.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on L2 Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.